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Abstract
Cantaloupe line CZW-30 containing coat protein gene constructs of cucumber mosaic cucumovirus (CMV), zucchini
yellow mosaic potyvirus (ZYMV), and watermelon mosaic virus 2 potyvirus (WMV-2) was investigated in the
field over two consecutive years for resistance to infections by CMV, ZYMV, and/or WMV-2. Resistance was
evaluated under high disease pressure achieved by mechanical inoculations and/or natural challenge inoculations
by indigenous aphid vectors. Across five different trials, homozygous plants were highly resistant in that they never
developed systemic symptoms as did the nontransformed plants but showed few symptomatic leaves confined close
to the vine tips. Hemizygous plants exhibited a significant delay (2–3 weeks) in the onset of disease compared to
control plants but had systemic symptoms 9–10 weeks after transplanting to the field. Importantly, ELISA data
revealed that transgenic plants reduced the incidence of mixed infections. Only 8% of the homozygous and 33% of
the hemizygous plants were infected by two or three viruses while 99% of the nontransformed plants were mixed
infected. This performance is of epidemiological significance. In addition, control plants were severely stunted
(44% reduction in shoot length) and had poor fruit yield (62% loss) compared to transgenic plants, and most of
their fruits (60%) were unmarketable. Remarkably, hemizygous plants yielded 7.4 times more marketable fruits
than control plants, thus suggesting a potential commercial performance. This is the first report on extensive field
trials designed to assess the resistance to mixed infection by CMV, ZYMV, and WMV-2, and to evaluate the yield
of commercial quality cantaloupes that are genetically engineered.
Introduction
Melon (Cucumis melo L.), one of the world’s major
cucurbit crops, is susceptible to numerous viral dis-
eases resulting in economic losses in most produc-
tion areas [3, 6, 13, 17, 19, 23, 24, 27, 28]. The
four most important viruses, cucumber mosaic cucu-
movirus (CMV), watermelon mosaic virus 2 potyvirus
(WMV-2), zucchini yellow mosaic potyvirus (ZYMV)
and papaya ringspot potyvirus type w (PRSV-w) are
widespread in temperate as well as tropical regions of
the world [20], and are readily transmitted by several
aphid species in a nonpersistent manner.
WMV-2, ZYMV, and PRSV-w are members of the
genus potyvirus in the potyviridae plant virus family.
Potyvirus particles are filamentous and about 750 nm
long with a monopartite genome composed of a single-
stranded RNA species. The coat protein (CP) genes are
localized at the extreme 3’ end of their respective open
reading frames. The CP is expressed by proteolytic
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cleavage from the virus-encoded polyprotein [33]. In
melons, WMV-2, ZYMV, and PRSV-w induce similar
foliar symptoms including systemic chlorosis, mosa-
ic, severe leaf deformation, vein banding, reduced leaf
laminae, and plant stunting [38]. WMV-2 and ZYMV
are distantly related serologically but have no serolo-
gical relationship with PRSV-w.
CMV is the type species of the genus cucumovirus
in the bromoviridae plant virus family. CMV particles
are isometric with a diameter of about 29 nm, and con-
tain a multipartite genome composed of three single-
stranded RNA species. The CMV CP gene is located
at the extreme 30 end of RNA 3 but is expressed by
subgenomic RNA 4 [25]. In melons, CMV induces
systemic mosaic, mottling, prominent downward curl-
ing of leaves, chlorosis, reduced leaf laminae, and plant
stunting [38].
Coat protein-mediated protection (CPMP) [9, 12,
18] constitutes a major breakthrough to facilitate the
incorporation of genetically-based multiple virus res-
istance in crop plants. Transgenic potato lines with
dual resistance to potato virus X potexvirus and potato
virus Y potyvirus have been developed [15, 16]. In
cucurbits, transgenic squash with resistance to two
and three viruses have been obtained. A transgenic
F1 hybrid squash containing the ZYMV and WMV-
2 CP genes and tested under the code identification
ZW-20 showed excellent resistance to mixed infec-
tions by both potyviruses [1, 4, 10, 36]. In 1995, this
hybrid, marketed as cv. Freedom II, became the first
virus-resistant transgenic crop released commercially
in the USA. Another transgenic squash line designated
CZW-3 and containing the CP genes of CMV, ZYMV,
and WMV-2 is resistant to these three viruses [36].
In melon, transgenic lines with single resistance to
CMV [11, 37] or ZYMV [8] were developed using
CPMP. The first transgenic cantaloupes with multiple
virus resistance were developed lately by the Asgrow
Seed Company. These plants contain the CP genes of
CMV, ZYMV, and WMV-2 and are resistant to these
three viruses. Recently, transgenic homozygous and
several hemizygous plants were tested in a field envir-
onment against ZYMV and WMV-2 [4]. Transgenic
plants had a significantly lower visual disease rating
than did the controls. No virus was detected in homo-
zygous plants by enzyme-linked immunosorbent assay
whereas only a few hemizygous plants were infected
by ZYMV (6%) but none by WMV-2. In contrast, 57
and 8.5% of the control plants were infected by ZYMV
and WMV-2, respectively. In this study, dual infections
by ZYMV and WMV-2 were not investigated and res-
istance to CMV was not evaluated. Also, yield was not
analyzed.
We report here on the evaluation of one transgen-
ic cantaloupe line containing the CP genes of CMV,
ZYMV and WMV-2, designated CZW-30, for resist-
ance to infections by CMV, by CMV and ZYMV, and
by CMV, ZYMV, and WMV-2. We analyzed in the field
the resistance of homozygous and hemizygous plants
to natural infections by aphid vectors, monitored infec-
tion rates by ELISA, and assessed yield. Transgenic
line CZW-30 was highly resistant to mixed infections
by the three aphid-borne viruses and yielded signific-
antly more marketable fruits than untransformed con-
trols.
Materials and methods
CP gene constructs and plant material
The CP genes of CMV, ZYMV and WMV-2, and the
binary vectors carrying their expression cassettes were
previously described [31, 36]. Briefly, the expression
cassettes for the ZYMV and WMV-2 CP genes were
engineered into one binary vector [36] and the CP gene
of CMV was cloned separately into a second binary
vector [31]. Expression of each CP gene was driv-
en by the cauliflower mosaic virus (CaMV) 35S pro-
moter, part of the intergenic region of RNA 3 of CMV
strain C used as leader sequence, and the nopaline
synthase terminator or the CaMV 35S terminator [34,
36]. Agrobacterium-mediated transformation was car-
ried out using cotyledonary explants of two propriet-
ary Asgrow western shipper cantaloupe inbreds using
a modification of the procedure described by Horsch
et al. [14]. Transgenic R0 plants were recovered by
selection on kanamycin and subsequently established
in the greenhouse. All transgenic plants and seeds were
produced by the Asgrow Seed Company.
Transgenic line CZW-30 was produced by progeny
selection of a cross of two transgenic lines designated
ZW-102 and C-73-6. Line ZW-102 contained the CP
genes of ZYMV strain FL and WMV-2 strain FL [36].
Line C-73-6 contained the CP gene of CMV strain
C [31]. These two lines showed high levels of virus
resistance in greenhouse and field experiments con-
ducted in 1992 and 1993. Lines ZW-102 and C-73-
6 were crossed and their progeny screened for virus
resistance. Among the progeny tested, line CZW-30
exhibited high level of virus resistance in the green-
house and in the field. This latter was developed to
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homozygozity and a hemizygous hybrid CZW-30 was
subsequently obtained. The presence of the CP genes
was verified in resistant plants throughout these exper-
iments by polymerase chain reaction using genomic
DNA and appropriate primers.
Transplant production, virus isolates, and mechanical
inoculations
Seeds were sown directly into peat pots contain-
ing Cornell mix [10]. The homozygous line CZW-
30 and untransformed cv. Mission were tested in
1994, whereas the homozygous and hemizygous CZW-
30 and untransformed cv. Cristobal were analyzed
in 1995. Mission and Cristobal are two proprietary
Asgrow hybrids that are susceptible to CMV, ZYMV
and WMV-2. Some seedlings were mechanically-
inoculated in the greenhouse approximately 12–15
days post-germination when they showed 2–3 expan-
ded leaves. CMV strain Fny [2], ZYMV strain FL
[30], and WMV-2 strain Rob [10] or WMV-2 strain
NY were used as inocula. These strains of CMV and
WMV-2 differed from those used to engineer the CP
genes [31, 36] whereas the same strain of ZYMV was
used in the CP gene engineering and in the field tests
[36].
In 1994, half of the transgenic and half of the
untransformed plants were inoculated by rubbing
Corundum-dusted cotyledons and expanded leaves
with diluted inoculum. This approach was chosen to
guarantee resistance data in case natural virus spread
by aphid vectors would be unreliable. For inoculations
with single viruses, 1:50 dilutions of crude sap from
CMV, ZYMV or WMV-2 infected squash cv. Pres-
ident were used. To prepare one inoculum consisting
of CMV and ZYMV, and another consisting of CMV,
ZYMV and WMV-2, we mixed 1:25 (1:1, v:v) and 1:15
(1:1:1, v:v:v) dilutions, respectively, of crude sap from
squash cv. President infected by one of these viruses.
Given the efficient natural virus spread in 1994, only
untransformed plants were mechanically inoculated in
1995. After inoculation, plantlets were maintained for
one week in screenhouses before being transplanted in
the fields.
Experimental design and field layout
Field trials were carried out under permits issued by
APHIS-USDA. Five isolated field sites, designated A
to E, were selected on three different experimental
farms at the New York State Agricultural Experiment
Station in Geneva, NY. Field A was located in farm 1,
fields B and C were located 500 m apart in farm 2, and
fields D and E were 250 m apart in farm 3.
In 1994, trials were set in fields A to C. The res-
istance of homozygous plants was evaluated against
CMV in field A, against CMV and ZYMV in field
B, and against CMV, ZYMV and WMV-2 in field C.
Complete block designs were used with two treatments
(mechanically inoculated and uninoculated plants),
each treatment representing half of the plant pop-
ulation. Treatments were allocated randomly into
6 blocks. To facilitate uniform distribution of the
inoculum throughout each field, additional mechanic-
ally inoculated untransformed plants were transplanted
at pre-determined locations. These additional virus
source plants were infected by CMV in field A, CMV
or ZYMV in field B, and CMV, ZYMV or WMV-2 in
field C. They represented 10–15% of the total number
of plants in each field. Seedlings were transplanted on
bare soil 1.2 m apart and 3.6 m between rows. The size
of the plots was: 20 m30 m for field A, 22 m30 m
for field B, and 28 m45 m for field C. No insecticides
were used since one of the objectives was to evaluate
resistance to natural infection by aphid vectors.
In 1995, trials were set in replicated fields D and
E. The resistance of transgenic homozygous and hem-
izygous plants was evaluated against aphid inocula-
tions of CMV, ZYMV, and WMV-2 in a complete
block design. Plants were allocated randomly into 6
blocks. The size of each plot was 35 m 45 m. Mech-
anically inoculated untransformed plants were planted
as border rows consisting of successive groups of 3
plants inoculated either with CMV, ZYMV or WMV-2.
These inoculated control plants served as primary virus
sources to simulate natural conditions of virus spread
by aphid vectors. Rows were covered with black poly-
ethylene mulch (1.8 m wide), and a single drip irriga-
tion line was placed in the bed center.Sevin was applied
when needed to control beetle populations, otherwise
no insecticides were used.
Data collection on resistance, plant vigor and fruit
yield
Disease incidence was assessed by monitoring symp-
tom development every 3–7 days in 1994 and 1995.
Enzyme-linked immunosorbent assay (ELISA) was
used to identify the virus(es) causing symptoms and
discriminate between single and mixed infections.Leaf
samples in positions 1–8 at the apical end of the longest
vines of each plant were collected randomly 3–4 times
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throughout both growing seasons and stored in zip-
lock bags at  20 C until processed. Processing of
leaf tissue, -globulins, conjugates, ELISA conditions,
and data analysis were as previously described [10]. If
ELISA results were ambiguous,bioassays were carried
out on Nicotiana benthamiana, Phaseolus vulgaris cv.
Black turtle 2, Chenopodium quinoa and squash cv.
President. N. benthamiana is susceptible to WMV-2
and CMV but not to ZYMV, P. vulgaris cv. Black
turtle 2 is susceptible to WMV-2 but not to CMV and
ZYMV. Squash and C. quinoa are systemic and local
lesion hosts for the three viruses, respectively.
Shoot length of the longest vine was measured for
each plant as one of the parameters indicative of growth
and vigor. Data was collected once at the end of the
trial period in 1994, and at three different dates in 1995.
Fruit yield was measured in 1995 at three different
dates by counting the number of fruits and measuring
the fresh fruit weight. Also, marketable quality was
rated by considering fruit size, shape, and flesh firm-
ness. Fruits were rated as unmarketable if they were
misshapen or <10 cm in diameter.
Statistical analysis
Data collected on symptom development, ELISA, fruit
number, fruit weight, and shoot length were analyzed
by ANOVA using SAS [32].
Results
1994 field trials
Resistance to infections by CMV
Transgenic homozygous cantaloupes CZW-30 were
evaluated for resistance to CMV in field A. All untrans-
formed plants developed systemic symptoms includ-
ing mosaic, chlorosis, mottling, prominent downward
curling of leaves, reduced leaf laminae, and plant stunt-
ing. These symptoms persisted throughout the grow-
ing season. Incidence of CMV was noticeably higher
early in the season for mechanically inoculated than for
uninoculated untransformed plants (data not shown).
However, all aphid-inoculated untransformed plants
were symptomatic at 48 days after planting (dpp) (Fig-
ure 1A).
In contrast, transgenic plants never showed system-
ic CMV symptoms (Figure 1A). Instead, transgenic
plants developed localized CMV symptoms that were
clearly distinct and milder than those of untransformed
plants. First, localized symptoms were confined to
some leaves located close to the vine tips. Second,
symptomatic leaves showed a downward curling and
mosaic but had no reduction of leaf size, and plants
were not stunted. Third, transgenic plants appeared
to outgrow the symptoms since most of the newly
developed leaves were asymptomatic. Fourth, symp-
toms were substantially attenuated throughout the sea-
son but became more severe at the end of the grow-
ing season (68 dpp). The percentage of transgenic
plants with localized symptoms increased from 22%
at 48 dpp to 56% at 54 dpp, and reached 100% by
68 dpp. Remarkably, transgenic plants reacted similar
whether they were mechanically- or aphid-inoculated.
ELISA was used to characterize the incidence of
infecting viruses with leaf samples collected 28, 48 and
68 dpp. CMV ELISA-positive untransformed plants
increased from 19.5 to 93% by 28 and 68 dpp, respect-
ively (Table 1). Conversely, only 14.5% of the trans-
genic plants were ELISA-positive for CMV by 68 dpp.
Although all transgenic plants displayed some local-
ized CMV symptoms by the end of the growing sea-
son, only a few (14.5%) reacted positively for CMV
in ELISA. The difference in the percentage of plants
exhibiting visual symptoms and the percentage of
ELISA positive plants was apparently due to the reac-
tion of the transgenic plants and the sample collection
method. Only young leaves at the extremity of the main
vines were collected for ELISA, and most of the symp-
tomatic transgenic plants did not exhibit symptoms on
these collected leaves. ELISA also revealed a high
incidence of potyvirus infection for the untransformed
plants since 85 and 23% were positive for WMV-2 and
ZYMV, respectively (Table 1). Plants infected by these
two potyviruses developed symptoms that were distinct
from those caused by CMV. Potyvirus-infected plants
showed interveinal chlorosis, blisters, vein banding
and severe leaf deformation. These symptoms were
observed first on a few plants (5%) by 40 dpp, but
on nearly all (95%) by 58 dpp. In contrast, none of
the transgenic plants reacted for WMV-2 and ZYMV
(Table 1). The presence of PRSV-w was also surveyed
by ELISA but it was not detected in field A.
Untransformed plants showed a 34% reduction in
shoot length at 68 dpp compared to transgenic plants
(104  25 vs 157  29 cm). These differences were
significant (P < 0:01) (data not shown).
Analysis of variance was used to determine which
factor (genotype, treatment, time of data collection)
most influenced the differences observed. Results
molb45us.tex; 10/07/1997; 15:23; v.7; p.4
283
Figure 1. Disease progress curves on homozygous (open diamond) and hemizygous (open circle) cantaloupes CZW-30 containing the CP genes
of CMV, ZYMV, and WMV-2 and untransformed cantaloupes (solid rectangle) under field conditions of infection by CMV (A), CMV and
ZYMV (B), CMV, ZYMV and WMV-2 (C) in 1994, and CMV, ZYMV and WMV-2 (D) in 1995. Data represent the cumulative percentage of
plants that showed systemic foliar symptoms (mosaic, chlorosis, mottling, downward curling of leaves, and reduced leaf laminae) due to aphid
inoculations.
Table 1. Resistance evaluation of transgenic homozygous cantaloupes CZW-30 containing the CP genes of CMV, ZYMV, and WMV-2
to infections by CMV during the 1994 growing season.
Genotype Treatment n Percent of ELISA-positive plants for CMVa Contaminating virusesb
Aug. 4 (28 dpp) Aug. 24 (48 dpp) Sep.13 (68 dpp) ZYMV WMV-2
Transgenic plants
CZW-30 uninoculated 26 0 0 12 0 0
inoculated CMV 24 8 8 17 0 0
Untransformed plants
Mission uninoculated 20 15 47 90 15 85
inoculated CMV 46 24 87 96 31 85
a Data represent cumulative percentage of ELISA-positive plants for CMV at 28, 48, and 68 days after planting (dpp). Infected plants
had OD 405 nm readings at least 8 times higher than control plants (1.2 vs. 0.14) after 30 min substrate hydrolysis. Uninfected transgenic
plants had OD 405 nm values of 0.35 after 30 min substrate hydrolysis.
n = number of plants tested. Plants were either uninoculated or mechanically inoculated with CMV-Fny (CMV) on June 23, and
transplanted to the field on July 7, 1994.
b Percent of ELISA positive plants by 68 dpp. ZYMV, zucchini yellow mosaic virus; WMV-2, watermelon mosaic virus 2.
molb45us.tex; 10/07/1997; 15:23; v.7; p.5
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showed that genotype was the only significant factor
accounting for the variations in symptom development,
virus incidence, and shoot length among test plants
(P < 0:01). The inoculation method, e.g. mechanical
versus aphid inoculation, and the interaction between
genotype and inoculation method were not significant
(P > 0:2). Also, blocking effects were not significant
(P > 0:3).
Resistance to infections by CMV and ZYMV
Transgenic homozygous cantaloupes CZW-30 were
evaluated for resistance to mixed infections by
CMV and ZYMV in field B. Untransformed plants
developed systemic CMV-type symptoms similar to
those described for their counterparts in field A
except for additional severe ZYMV-type leaf deform-
ations, blisters, yellowing and systemic vein clear-
ing. These symptoms persisted throughout the grow-
ing season. Virus incidence was significantly higher
early in the season for mechanically inoculated than
for uninoculated untransformed plants, but all untrans-
formed plants were symptomatic 54 dpp (Figure 1B).
In contrast, transgenic plants were highly resistant
throughout the growing season since nearly all of them
(94%) never developed systemic symptoms. However,
a number of transgenic plants (72% by the end of
the growing season, e.g. 74 dpp) had non-systemic
symptoms and these were clearly distinct from those
exhibited by untransformed plants.Symptomatic trans-
genic plants developed localized symptoms that were
identical to those previously described for the trans-
genic plants in field A (see above) with the addition of
discrete yellowing and vein clearing.
ELISA data of leaf samples collected 26, 42, 57,
and 74 dpp are summarized in Table 2. All untrans-
formed plants (99%) were positive for CMV and/or
ZYMV by 57 dpp, and the majority (75%) was mixed
infected by CMV and ZYMV by 74 dpp. The res-
ults with transgenic plants were markedly different.
Only 38.5% of the latter were infected by CMV
and/or ZYMV by 74 dpp, with CMV being dominant
(30.5%). Mixed infections by both CMV and ZYMV
were observed in only 3% of the transgenic plants.
Untransformed plants also reacted in ELISA for WMV-
2 (64%) but none of the transgenic plants did (Table 2).
ELISA revealed the presence of the nematode-borne
tobacco ringspot nepovirus (TRSV) in some transgen-
ic (6.5%) and untransformed (21%) plants (Table 2).
TRSV accounted for the few transgenic plants (6%)
that showed severe symptoms consisting of chlorotic
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spots and foliar necrosis at the end of the growing sea-
son (Figure 1B). PRSV-w was not detected in field B.
By the end of the season (68 dpp), untransformed
plants were severely stunted with a 42% reduction in
shoot length compared to transgenic plants (7629 vs
13435 cm). These differences were significant (P <
0:01) (data not shown). Identical to field A, analysis of
variance showed that genotype was the only significant
factor that accounted for the differences in symptom
development, virus incidence and shoot length among
plants (P < 0:01).
Resistance to infections by CMV, ZYMV, and WMV-2
Transgenic homozygous cantaloupes CZW-30 were
evaluated for resistance to CMV, ZYMV, and WMV-
2 in field C. Untransformed plants developed sys-
temic symptoms similar to those described for field
B due to mixed infections by CMV and the two
potyviruses. Although more mechanically inoculated
untransformed plants were infected early in the sea-
son compared to uninoculated untransformed plants,
all untransformed plants were symptomatic by 55 dpp
(Figure 1C). In contrast, transgenic plants were highly
resistant throughout the growing season since the
majority of them never developed systemic symptoms.
However, some transgenic plants (81% by the end
of the growing season, e.g. 77 dpp) developed non-
systemic symptoms and these were clearly distinct
from those observed on untransformed plants. Sympto-
matic transgenic plants displayed the localized reaction
previously described for their counterparts in fields A
and B.
ELISA was performed with leaf samples collected
26, 41, 58, and 73 dpp. At least one of the target viruses
was detected in 39% of the aphid-inoculated untrans-
formed plants at 26 dpp, in 94% at 41 dpp, and in 100%
at 58 dpp. In contrast, only 15% of the transgenic plants
were ELISA positive at 58 dpp. Table 3 summarizes the
cumulative data at 73 dpp. Mixed infections by CMV,
ZYMV and WMV-2 were very low in transgenic plants
when compared to untransformed plants. Only 5.5%
of the latter were infected by CMV and ZYMV while
72% of the untransformed plants had mixed infections
(Table 3). PRSV-w was detected in 4.5 and 4% of
transgenic and untransformed plants, respectively, and
TRSV was found in 31.5 and 26% of transgenic and
untransformed plants, respectively (Table 3). PRSV-
w and TRSV accounted for the few (10%) transgen-
ic plants that showed severe foliar symptoms starting
64 dpp (Figure 1C).
By the end of the growing season (73 dpp), untrans-
formed plants were severely stunted with a 36% reduc-
tion in shoot length compared to transgenic plants
(80  21 vs 125  28 cm). These differences were
significant (P < 0:05) (data not shown). Genotype
was the only significant factor accounting for the vari-
ations observed among plants (P < 0:01), like for the
two previous fields.
1995 field trials
Resistance of transgenic homozygous and hemizygous
plants to infections by CMV, ZYMV, and WMV-2
Transgenic homozygous and hemizygous cantaloupes
CZW-30 were compared for their resistance to mixed
infections by CMV, ZYMV, and WMV-2 in replicated
fields D and E. Unlike the 1994 field trials, plants were
not mechanically inoculated. Instead, border rows of
untransformed plants infected with one of the three
target viruses served as virus sources. Analysis of
symptom development indicated that susceptible con-
trol plants displayed similar reactions in both fields
D and E with 89 and 100% symptomatic plants by
32 and 46 dpp, respectively (Figure 1D). Symptoms
were as previously described for fields A, B and C,
except that symptoms caused by non-targeted viruses
were not observed. Transgenic plants exhibited resist-
ance in both fields D and E (Figure 2). Homozygous
plants never developed systemic symptoms throughout
the growing season, but a few plants (3.5 and 7% by
46 and 65 dpp, respectively) showed localized symp-
toms similar to those described previously for fields
A, B, and C. In contrast, hemizygous plants developed
systemic symptoms similar to those exhibited by con-
trol plants, but they became symptomatic significantly
later than the controls. For example, the percentage of
symptomatic hemizygous plants was 15% compared
to 89% symptomatic control plants at 32 dpp. Con-
sequently, hemizygous plants were substantially larger
and more vigorous than control plants (Figure 2). Virus
incidence in hemizygous plants increased from 76 to
100% by 46 and 65 dpp, respectively. Symptoms were
monitored only up to 65 dpp because transgenic plants
were difficult to score individually late in the growing
season due to their vigorous growth.
ELISA of leaf samples collected 34, 79, and
102 dpp confirmed that nearly all untransformed con-
trol plants (91%) became infected by 34 dpp. At the
end of the trial period (102 dpp), all controls were
ELISA positive and 99% of them were infected at least
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Table 3. Virus incidence in transgenic homozygous CZW-30 and untransformed cantaloupes after mixed infections by CMV, ZYMV,
and WMV-2 at 73 days after planting during the 1994 growing season.
Genotype Treatment n Percent of ELISA-positive plants for CMVa Contaminating virusesb
(+) CZW CZ CW ZW C Z W TRSV PRSV-w
Transgenic plants
CZW-30 uninoculated 54 39 0 7 0 0 17 15 0 35 7
inoc. C+Z+W 50 32 0 4 0 0 18 10 0 28 2
Untransformed plants
Mission uninoculated 33 100 24 28 0 15 3 30 0 9 3
inoc. Z 37 100 37 30 0 14 0 19 0 46 0
inoc. W 41 100 24 25 0 17 0 34 0 20 5
inoc. C 41 100 32 24 0 17 0 27 0 29 9
a Data represent cumulative percentage of ELISA-positive plants for CMV+ZYMV+WMV-2 (CZW), CMV+ZYMV (CZ),
ZYMV+WMV-2 (ZW), CMV (C), ZYMV (Z), and WMV-2 (W) on Sep. 16, e.g. 73 days post-planting (dpp). Infected plants
had OD 405 nm values at least 11–24 times higher (0.7 vs. 0.06 for CMV, 1.1 vs. 0.06 for ZYMV, and 1.2 vs. 0.05 for WMV-2) than
healthy control plants after 30 min substrate hydrolysis. Uninfected transgenic plants had OD 405 nm values of 0.1 for CMV, 0.1 for
ZYMV, and 0.05 for WMV-2 after 30 min substrate hydrolysis.
n = number of plants tested, (+) total percent of ELISA positive plants. Plants were either uninoculated or mechanically-inoculated
(inoc.) with CMV-Fny (C), ZYMV-FL (Z), or WMV-2-Rob (W), or a mixture of CMV+ZYMV+WMV-2 (C+Z+W) on June 21,
and transplanted to the field on July 5, 1994.
b Percentage of ELISA-positive plants by 73 dpp. PRSV-w = papaya ringspot virus type w.
Figure 2. Yield of transgenic CZW-30 and untransformed cantaloupes during the 1995 growing season. Data on total number of fruits (open
bars) and marketable fruits (solid bars) were taken for homozygous (stripped bars), hemizygous (black bars), and untransformed plants (stippled
bars) at 74, 81, and 88 dpp. Data represent the average of cumulative values for 96 plants of each genotype that were tested in two separate
fields. Line on top of bars represent standard deviations.
by two viruses (Table 4). In contrast, only 34% of
homozygous plants reacted in ELISA, and only 8%
had combinations of viruses by 102 dpp (Table 4).
Hemizygous plants had a higher incidence of ELISA
positive plants (70% by 102 dpp) than homozygous
plants. However, the incidence of mixed infections by
two or three viruses was significantly lower (33%) for
hemizygous than for control plants (99%) at the end of
the growing season (Table 4).
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Table 4. Virus incidence in transgenic CZW-30 and untransformed cantaloupes after mixed infections
by CMV, ZYMV, and WMV-2 at 102 days after planting during the 1995 growing season.
Genotype n Field Percent of ELISA-positive plantsa
(+) CZW CZ CW ZW C Z W
Transgenic plants
Homozygous CZW-30 96 D 32 0 5 0 1 21 1 4
96 E 36 0 1 3 6 4 6 16
Hemizygous CZW-30 96 D 70 6 14 1 10 16 18 5
96 E 70 7 6 4 18 9 8 16
Untransformed plants
Cristobal 96 D 100 21 78 0 0 0 1 0
96 E 100 72 20 0 7 0 1 0
a Data represent cumulative percentage of ELISA-positive plants for CMV+ZYMV+WMV-2 (CZW),
CMV+ZYMV (CZ), CMV+WMV-2 (CW), ZYMV+WMV-2 (ZW), CMV (C), ZYMV(Z), and WMV-
2 (W) on Sep. 15, e.g. 102 days after planting (dpp). Infected plants had OD 405 nm readings at least
11–18 times higher (1.1 vs. 0.06 for CMV, 0.7 vs. 0.06 for ZYMV, 0.5 vs 0.03 for WMV-2) than control
plants after 30 min substrate hydrolysis. Uninfected transgenic plants had OD 405 nm values of 0.06 for
CMV, 0.05 for ZYMV, and 0.03 for WMV-2. Infected plants were all aphid-inoculated.
n = number of plants tested in two separate fields designated D and E, (+) total percentage of ELISA-
positive plants. Untransformed plants used as primary virus sources were mechanically-inoculated with
CMV-Fny, ZYMV-FL or WMV 2-NY on May 31. Seedlings were transplanted to the fields on June 5,
1995.
Shoot length values were averaged for fields D and
E. Data confirmed visual observations that transgenic
plants were more vigorous and longer than controls
(Figure 2). Control plants were severely stunted by
26 dpp with a 33% reduction in shoot length com-
pared to transgenic plants (96 18 vs. 143 21 cm).
Growth differences between control and transgenic
plants were even more apparent later in the grow-
ing season (62 dpp) when controls showed 38 and
49% reductions relative to hemizygous (109 22 vs.
175  25 cm) and homozygous (109  22 vs. 215
vs. 23 cm) plants, respectively. Homozygous and hem-
izygous plants showed similar growth at 26 and 50 dpp,
but homozygous plants had significantly longer vines
(P < 0:01) at 62 dpp (215 23 vs. 175 25 cm).
Yield of transgenic plants
Figure 3 shows the cumulative number of fruits that
were harvested at three different dates. Transgen-
ic plants had significantly higher marketable yield
than untransformed controls (P < 0:01). Hemizygous
plants produced 322 fruits of which 264 (82%) were
marketable, and homozygous plants had 185 fruits with
159 (86%) being of marketable quality. Fruits from
transgenic plants were uniform in size (diameter 11.5–
14 cm) and had good flesh quality (data not shown).
Unmarketable fruits were mostly immature at harvest
time or had mushy flesh. Control plants showed a sig-
nificantly lower yield (P < 0:01) with only 88 fruits
(Figure 3). This value represents a 52 and 73% yield
reduction compared to homozygous and hemizygous
plants, respectively. Moreover, 53 out of the 88 (60%)
fruits were unmarketable because they were small in
size or misshapen. Average individual fruit weight
was identical for homozygous and hemizygous plants
(1.2 kg), but was significantly reduced (P < 0:01) by
58% for control plants (0.5 kg). Analysis of variance
indicated that genotype was the only significant factor
accounting for all the variations observed among plants
(P < 0:01).
Discussion
Homozygous cantaloupes CZW-30 containing the CP
genes of CMV, ZYMV, and WMV-2 showed excellent
resistance under field conditions where either one, two
or all three aphid-borneviruses were deliberately intro-
duced. Homozygous plants never exhibited systemic
symptoms upon infections by CMV, ZYMV and/or
WMV-2. However, some plants developed localized
symptoms that were clearly distinct from those of con-
trol plants because they were substantially milder and
confined to a few leaves near the growing point of the
plants. In addition, homozygous plants outgrew these
symptoms. More importantly, although some homo-
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Figure 3. Resistance of cantaloupes CZW-30 to mixed infections by CMV, ZYMV and WMV-2 in field D in 1995. The two right and two left
rows contain homozygous and hemizygous plants, respectively, and the two center rows contain control plants that show severe stunting and
foliar symptoms. The photograph was taken 53 days after planting.
zygous plants became symptomatic late in the growing
season, symptoms were not caused by mixed infec-
tions but were primarily due to single infections by
one of the three viruses. Our data were highly repro-
ducible over two consecutive years regardless of the
experimental design.
The development of transgenic line CZW-30 is
especially significant because of its resistance to three
of the four most important cantaloupe viruses and its
commercially desirable fruit quality. A resistant canta-
loupe line with multiple virus resistance has not been
previously developed, essentially because of the diffi-
culties in co-transferring and selecting multiple resist-
ance genes by classical breeding [22, 29]. In addition,
the numerous genes involved in conferring the resist-
ance, their location on different loci, and their linkage
to undesirable traits have made it a more difficult chal-
lenge for conventional breeders.
Homozygous line CZW-30 was used as resist-
ant germ plasm to transfer the resistance to CMV,
ZYMV, and WMV-2 into hemizygous plants. Seed
companies generally prefer hybrids for their superior
yield and to protect proprietary rights once the seeds
are commercialized. Although hemizygous CZW-30
plants developed systemic symptoms late in the season,
they had significantly higher fruit yield than homozyg-
ous plants eventhough the latter developed only local-
ized symptoms. Even more striking was the 7.4-fold
increase in fruit yield of the hemizygous over the sus-
ceptible control plants. Athough the control cultivar
was not the exact genotype as the hemizygous plants,
the latter clearly outperformed the control plants.Hem-
izygous CZW-30 plants substantially limited the incid-
ence of CMV, ZYMV and WMV-2 before and during
fruit setting, hence marketable fruits were produced.
Thus, our data suggest that commercial hybrids ori-
ginating from the homozygous line CZW-30 should
perform well under severe disease incidence of CMV,
ZYMV, and WMV-2. Our study expands on the recent
report by Clough and Hamm [4] who evaluated homo-
zygous and several hemizygous plants expressing the
CP genes of CMV, ZYMV and WMV-2 for resistance
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to ZYMV and WMV-2. These authors found that trans-
genic plants were highly resistant to the two potyvir-
uses. However, they did not investigate the resistance
to CMV nor evaluated yield.
Unexpectedly, a differential degree of resistance
was observed between homozygous and hemizygous
plants. Some homozygous plants developed localized
symptoms that were confined to a few leaves close to
the extremity of the vines and the symptoms became
attenuated as the leaves expanded. In contrast, hem-
izygous plants showed a delay in the onset of disease
but finally developed systemic symptoms comparable
to those observed on control plants. A difference in
virus incidence was noticed previously between homo-
zygous and hemizygous cantaloupes expressing the
three CP genes, however, the authors did not discuss
this difference [4]. There have been limited reports on
transgenic plants of economic importance that show
differential resistance depending on the level of zygos-
ity for the viral transgenes. Recently, Di et al. [7]
suggested that homozygous but not hemizygous soy-
bean plants containing a CP precursor of bean pod
mottle comovirus were resistant to mechanical inocu-
lations but these authors did not present any definit-
ive evidence. Pang et al. [26] showed that homozyg-
ous lettuce plants expressing the nucleocapsid gene
of tomato spotted wilt tospovirus were highly res-
istant to mechanical inoculations while hemizygous
plants were moderately resistant. Also, investigations
on RNA-mediated protection have indicated that trans-
genic homozygous tobacco lines expressing the 50
portion of the potato virus X potexvirus RNA [21]
and an antisense gene of the 50 end of the tobacco
mosaic tobamovirus RNA [5] displayed high resistance
while hemizygous plants of the same lines exhibited
very weak or no resistance. Interestingly, hemizygous
squash containing the CP genes of CMV, ZYMV, and
WMV-2 have performed well under field conditions [1,
4, 36].
For commercial purposes, the resistance exhib-
ited by transgenic CZW-30 plants against three of the
four major aphid-borne viruses affecting cantaloupes
in commercial production can still be broadened by
incorporating resistance against PRSV-w. Combining
host-encoded and virus-derived resistance appears to
be the strategy of choice to reach this objective.
Despite the benefits that virus-resistant plants offer
to agriculture, concerns have been raised regard-
ing their widespread commercial release. Potential
risks include the development of new viruses through
transencapsidation and recombination, and the escape
of transgenes into free-living crop relatives [35]. The
environmental risks due to heteroencapsidation and
recombination would appear to be minimal compared
to the use of untransformed plants since line CZW-
30 is significantly reducing the incidence of mixed
infections. This latter performance is of epidemiolo-
gical significance. However, the introgression of trans-
genes derived from viral genomes into wild relatives
has not been measured. We are currently addressing
these environmental issues to assess whether risks out-
weigh benefits.
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